Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any... Read more
Large Psilocybin Clinical Trial Paves the Way for Guided Sessions
Ryan Allway January 21st, 2020 News, Top News Psilocybin, popularly known as “magic mushrooms”, is a psychedelic drug with hallucinogenic properties. While it was studied during the 1960s for the treatment of several medical conditions, the Drug Enforcement Agency (DEA) labeled it a Schedule I Controlled Substance in 1970... Read more
Cannafornia strikes deal for Florida Super License, has opportunity to become one of 22 Florida Licensees
Ryan Allway January 20th, 2020 News, Top News SALINAS, Calif. (PRWEB) January 15, 2020 CEO of Cannafornia, Paul King, told us earlier today, “Cannafornia has made a name for itself in the most competitive market in the world, California, where there are over 6,000 active licensees, and a long... Read more
Xtraction Services Shares Commence Trading on the OTCQB Venture Market in the United States Under the Symbol XSHLF
Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any... Read more
YIELD GROWTH Subsidiary Flourish Mushroom Labs Appoints VP, Sales with Extensive Experience Selling Mushroom Products from Market Leader
Vancouver, British Columbia–(Newsfile Corp. – January 9, 2020) – The Yield Growth Corp. (CSE: BOSS) (OTCQB: BOSQF) (FSE: YG3) announces it has appointed seasoned sales expert Amber Allen as VP, Sales for Yield Growth’s Flourish Mushroom Labs Inc. Amber Allen joins Flourish Mushroom Labs Inc. as VP, Sales To view an... Read more
Isracann Receives Project Characterization Report and Engages EU GMP Consultancy
VANCOUVER, British Columbia, Jan. 09, 2020 (GLOBE NEWSWIRE) — Isracann Biosciences Inc.  (CSE: IPOT) (XFRA: A2PT0E) (OTC: ISCNF) (the “Company”) an Israel-based company focused on becoming a premier low cost, high quality cannabis producer for both domestic and European export sales, is pleased to advise it has received the results of... Read more
cbdMD Celebrates Inaugural National CBD Month as Official Founder
As the popularity of CBD continues to rise, millions of Americans are educating themselves on the prospective properties of CBD and how it can complement their everyday health and wellness routines. With a versatile array of CBD products to choose from, including tinctures, capsules, topicals, bath bombs, and a full... Read more
General Cannabis Announces Entry into Term Sheet to Acquire Hälsa Holdings Inc.
Acquisition will strengthen General Cannabis’s management team and add three revenue producing assets DENVER, Jan. 07, 2020 (GLOBE NEWSWIRE) — General Cannabis Corp (OTCQX: CANN), a company with deep domain expertise in providing services to the cannabis industry, today announced that it has signed a non-binding term sheet to... Read more
Xtraction Services Announces Sale of Non-Essential Equipment and Buy-Back of 13.4% of XS’ Outstanding Shares
Ryan Allway January 6th, 2020 News, Top News Xtraction Services Holding Corp., (“Xtraction Services”, “XS” or the “Company“) (CSE:XS) a specialty finance company engaged in equipment leasing in the United States, announced today that effective December 31, 2019, the Company has completed a transaction (the “Transaction”) with a vendor... Read more
The Yield Growth Corp. Accelerating Global Distribution and Seizing Opportunities in Psychedelic Research
Vancouver, British Columbia–(Newsfile Corp. – January 2, 2020) – The Yield Growth Corp. (CSE: BOSS) (OTCQB: BOSQF) (FSE: YG3) is pleased to announce increasing global distribution of its brands. Further, the company intends to become a leader in the exciting and burgeoning psychedelic medicine industry as the company continues to build... Read more
( ) ( ) ( ) ( ) ( ) ( ) ( ) ( )